Subscribe to RSS
DOI: 10.1055/a-1675-3840
Beyond the Psychoactive Effects of Ayahuasca: Cultural and Pharmacological Relevance of Its Emetic and Purging Properties
![](https://www.thieme-connect.de/media/plantamedica/202214/lookinside/thumbnails/10-1055-a-1675-3840_pmf0561-1.jpg)
Abstract
The herbal preparation ayahuasca has been an important part of ritual and healing practices, deployed to access invisible worlds in several indigenous groups in the Amazon basin and among mestizo populations of South America. The preparation is usually known to be composed of two main plants, Banisteriopsis caapi and Psychotria viridis, which produce both hallucinogenic and potent purging and emetic effects; currently, these are considered its major pharmacological activities. In recent decades, the psychoactive and visionary effect of ayahuasca has been highly sought after by the shamanic tourism community, which led to the popularization of ayahuasca use globally and to a cultural distancing from its traditional cosmological meanings, including that of purging and emesis. Further, the field of ethnobotany and ethnopharmacology has also produced relatively limited data linking the phytochemical diversity of ayahuasca with the different degrees of its purging and emetic versus psychoactive effects. Similarly, scientific interest has also principally addressed the psychological and mental health effects of ayahuasca, overlooking the cultural and pharmacological importance of the purging and emetic activity. The aim of this review is therefore to shed light on the understudied purging and emetic effect of ayahuasca herbal preparation. It firstly focuses on reviewing the cultural relevance of emesis and purging in the context of Amazonian traditions. Secondly, on the basis of the main known phytochemicals described in the ayahuasca formula, a comprehensive pharmacological evaluation of their emetic and purging properties is presented.
Key words
Banisteriopsis caapi - Psychotria viridis - Malpighiaceae - Rubiaceae - Ayahuasca - traditional Amazonian medicine - emetic - purgativePublication History
Received: 07 June 2021
Accepted after revision: 06 October 2021
Article published online:
18 November 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Miller MJ, Albarracin-Jordan J, Moore C, Capriles JM. Chemical evidence for the use of multiple psychotropic plants in a 1000-year-old ritual bundle from South America. Proc Natl Acad Sci U S A 2019; 116: 11207-11212
- 2 Ogalde JP, Arriaza BT, Soto EC. Identification of psychoactive alkaloids in ancient Andean human hair by gas chromatography/mass spectrometry. J Archaeol Sci 2009; 36: 467-472
- 3 Frecska E, Bokor P, Winkelman M. The therapeutic potentials of ayahuasca: Possible effects against various diseases of civilization. Front Pharmacol 2016; 7: 35
- 4 McKenna DJ. Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges. Pharmacol Ther 2004; 102: 111-129
- 5 Hamill J, Hallak J, Dursun SM, Baker G. Ayahuasca: Psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Curr Neuropharmacol 2018; 17: 108128
- 6 Domínguez-Clavé E, Soler J, Elices M, Pascual JC, Álvarez E, de la Fuente Revenga M, Friedlander P, Feilding A, Riba J. Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Brain Res Bull 2016; 126: 89-101
- 7 Chi T, Gold JA. A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses. J Neurol Sci 2020; 411: 116715
- 8 Kjellgren A, Eriksson A, Norlander T. Experiences of encounters with ayahuasca–“the vine of the soul”. J Psychoactive Drugs 2009; 41: 309-315
- 9 Brierley DI, Davidson C. Developments in harmine pharmacology – Implications for ayahuasca use and drug-dependence treatment. Prog Neuro-Psychopharmacology Biol Psychiatry 2012; 39: 263-272
- 10 Rodrigues AVSL, Almeida FJ, Vieira-Coelho MA. Dimethyltryptamine: Endogenous role and therapeutic potential. J Psychoactive Drugs 2019; 5: 299-310
- 11 Beyer SV. Singing to the Plants: A Guide to Mestizo Shamanism in the Upper Amazon. Albuquerque: University of New Mexico Press; 2011
- 12 Pinkley HV. Plant admixtures to ayahuasca, the South American hallucinogenic drink. Lloydia 1969; 32: 305-314
- 13 Rivier L, Lindgren JE. “Ayahuasca”, the South American hallucinogenic drink: An ethnobotanical and chemical investigation. Econ Bot 1972; 26: 101-129
- 14 Politi M, Friso F, Saucedo G, Torres J. Traditional use of Banisteriopsis caapi alone and its application in a context of drug addiction therapy. J Psychoactive Drugs 2020; 53: 76-84
- 15 Nagamine-Pinheiro N, Fagg CW, Gomes SM, Oliveira RC, Sonsin-Oliveira J. Vegetative anatomy, morphology and histochemistry of three species of Malpighiaceae used in analogues of the Amazonian psychoactive beverage ayahuasca. Flora Morphol Distrib Funct Ecol Plants 2021; 275: 151760
- 16 Gaujac A, Navickiene S, Collins MI, Brandt SD, de Andrade JB. Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices. Drug Test Anal 2012; 4: 636-648
- 17 DeKorne J, Aardvark D, Trout K. eds. Ayahuasca Analogues and Plant Based Tryptamines (The Best of The Entheogen Review 1992 – 1999, ER Monograph Series No. 1). 2nd ed.. ed. Sacramento, CA: The Entheogen Review; 2000
- 18 Ott J. Ayahuasca Analogues: Pangæan Entheogens. Kennewick, WA: Natural Books; 1994
- 19 Kaasik H, Souza RCZ, Zandonadi FS, Tófoli LF, Sussulini A. Chemical composition of traditional and analog ayahuasca. J Psychoactive Drugs 2021; 53: 65-75
- 20 McKenna DJ, Towers GHN, Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of ayahuasca. J Ethnopharmacol 1984; 10: 195-223
- 21 Ott J. Pharmahuasca: Human pharmacology of oral DMT plus harmine. J Psychoactive Drugs 1999; 31: 171-177
- 22 Prue R, Voss RW. Indigenous healing practice: Ayahuasca. Opening a discussion. J Pastoral Care Counsel 2014; 68: 6
- 23 Luna LE. Indigenous and Mestizo Use of Ayahuasca. An Overview. In: dos Santos RG. ed. The Ethnopharmacology of Ayahuasca. Trivandrum: Transworld Research Network; 2011: 1-20
- 24 Talin P, Sanabria E. Ayahuascaʼs entwined efficacy: An ethnographic study of ritual healing from ‘addiction’. Int J Drug Policy 2017; 44: 23-30
- 25 Politi M, Friso F, Mabit J. Plant based assisted therapy for the treatment of substance use disorders – part 2. Beyond blurred counderies. Rev Cult y Drog 2019; 24: 19-42
- 26 Politi M, Friso F, Mabit J. Plant based assisted therapy for the treatment of substance use disorders – part 1. The case of Takiwasi center and other similar experiences. Rev Cult y Drog 2018; 23: 99-126
- 27 Loizaga-Velder A, Verres R. Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence-Qualitative results. J Psychoactive Drugs 2014; 46: 63-72
- 28 da Silva MG, Daros GC, de Bitencourt RM. Anti-inflammatory activity of ayahuasca: Therapeutical implications in neurological and psychiatric diseases. Behav Brain Res 2021; 400: 113003
- 29 dos Santos RG, Osório FL, Crippa JAS, Hallak JEC. Antidepressive and anxiolytic effects of ayahuasca: A systematic literature review of animal and human studies. Rev Bras Psiquiatr 2016; 38: 65-72
- 30 Jiménez-Garrido DF, Gómez-Sousa M, Ona G, Dos Santos RG, Hallak JEC, Alcázar-Córcoles MÁ, Bouso JC. Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination. Sci Rep 2020; 10: 4075
- 31 dos Santos R, Bouso J, Hallak J, Alcazar-Corcoles M. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Rev Clin Pharmacol 2018; 11: 889-902
- 32 Orsolini L, Chiappini S, Papanti D, Latini R, Volpe U, Fornaro M, Tomasetti C, Vellante F, De Berardis D. How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy. Hum Psychopharmacol 2020; 35: e2728
- 33 Heise CW, Brooks DE. Ayahuasca exposure: Descriptive analysis of calls to US poison control centers from 2005 to 2015. J Med Toxicol 2017; 13: 245-248
- 34 Durante Í, dos Santos RG, Bouso JC, Hallak JE. Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects. Braz J Psychiatry 2021; 43: 362-369 DOI: 10.1590/1516-4446-2020-0913.
- 35 Sanz-Biset J, Cañigueral S. Plants as medicinal stressors, the case of depurative practices in Chazuta valley (Peruvian Amazonia). J Ethnopharmacol 2013; 145: 67-76
- 36 Mabit J. Ayahuasca in the treatment of addictions. In: Robert TB, Winkelman MJ. eds. Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. Santa Barbara: Greenwood Publishing Group; 2007: 87-103
- 37 Fotiou E, Gearin AK. Purging and the body in the therapeutic use of ayahuasca. Soc Sci Med 2019; 239: 112532
- 38 Luna LE. The concept of plants as teachers among four mestizo shamans of Iquitos, Northeastern Peru. J Ethnopharmacol 1984; 11: 135-156
- 39 Shepard GH. Psychoactive plants and ethnopsychiatric medicines of the matsigenka. J Psychoactive Drugs 1998; 30: 321-332
- 40 Rodriguez E, Cavin JC, West JE. The possible role of Amazonian psychoactive plants in the chemotherapy of parasitic worms – a hypothesis. J Ethnopharmacol 1982; 6: 303-309
- 41 Luna LE. Vegetalismo: Shamanism Among the Mestizo Population of the Peruvian Amazon (Stockholm Studies in Comparative Religion). Stockolm: Almqvist & Wiksell International; 1986
- 42 Fotiou E. Working with “La Medicina”: Elements of healing in contemporary ayahuasca rituals. Anthropol Conscious 2012; 23: 6-27
- 43 Mabit J, Giove R, Vega J. The Use of Amazonian Shamanism to rehabilitate Drug Addicts. In: Andritzky W. ed. Yearbook of Cross-Cultural Medicine and Psychotherapy. Berlin: VWB – Verlag für Wissenschaft und Bildung; 1996: 257-285
- 44 Shepard GH. Venenos divinos: Plantas psicoativas dos Matsigenka do Peru. In: Labate B, Goulart S. eds. O Uso Ritual Das Plantas de Poder. São Paulo: Mercado de Letras; 2005: 187-217
- 45 De Feo V. Ethnomedical field study in northern Peruvian Andes with particular reference to divination practices. J Ethnopharmacol 2003; 85: 243-256
- 46 Jauregui X, Clavo ZM, Jovel EM, Pardo-De-Santayana M. “Plantas con madre”: Plants that teach and guide in the shamanic initiation process in the East-Central Peruvian Amazon. J Ethnopharmacol 2011; 134: 739-752
- 47 Labate BC. The Internationalization of Peruvian Vegetalismo. In: Labate BC, Cavnar C. eds. Ayahuasca Shamanism in the Amazon and Beyond. NewYork: Oxford University Press; 2014: 183-205
- 48 Fotiou E. The globalization of ayahuasca shamanism and the erasure of indigenous shamanism. Anthropol Conscious 2016; 27: 151-179
- 49 Gearin AK, Labate BC. “La dieta”: Ayahuasca and the Western Reinvention of Indigenous Amazonian Food Shamanism. In: Labate BC, Cavnar C. eds. The Expanding World Ayahuasca Diaspora: Appropriation, Integration and Legislation. London: Routledge; 2018: 177-198
- 50 Schmid JT, Jungaberle H, Verres R. Subjective theories about (self-) treatment with ayahuasca. Anthropol Conscious 2010; 21: 188-204
- 51 Gearin A. Dividual vision of the individual: Ayahuasca neo-shamanism in Australia and the new age individualism orthodoxy. Int J Study New Relig 2016; 7: 199-220
- 52 Apud I. Ayahuasca from Peru to Uruguay: Ritual design and redesign through a distributed cognition approach. Anthropol Conscious 2015; 26: 1-27
- 53 Berlowitz I, Ghasarian C, Walt H, Mendive F, Alvarado V, Martin-Soelch C. Conceptions and practices of an integrative treatment for substance use disorders involving Amazonian medicine: Traditional healersʼ perspectives. Rev Bras Psiquiatr 2018; 40: 200-209
- 54 Souza RCZ, Zandonadi FS, Freitas DP, Tófoli LFF, Sussulini A. Validation of an analytical method for the determination of the main ayahuasca active compounds and application to real ayahuasca samples from Brazil. J Chromatogr B Anal Technol Biomed Life Sci 2019; 1124: 197-203
- 55 Lo Faro AF, Di Trana A, La Maida N, Tagliabracci A, Giorgetti R, Busardò FP. Biomedical analysis of new psychoactive substances (NPS) of natural origin. J Pharm Biomed Anal 2020; 179: 112945
- 56 Lesiak AD, Musah RA. Application of ambient ionization high resolution mass spectrometry to determination of the botanical provenance of the constituents of psychoactive drug mixtures. Forensic Sci Int 2016; 266: 271-280
- 57 Chambers MI, Appley MG, Longo CM, Musah RA. Detection and quantification of psychoactive N,N-dimethyltryptamine in ayahuasca brews by ambient ionization high-resolution mass spectrometry. ACS Omega 2020; 5: 28547-28554
- 58 Wang YH, Samoylenko V, Tekwani BL, Khan IA, Miller LS, Chaurasiya ND, Rahman MM, Tripathi LM, Khan SI, Joshi VC, Wigger FT, Muhammad I. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinsonʼs disease. J Ethnopharmacol 2010; 128: 662-671
- 59 Yritia M, Riba J, Ortuño J, Ramirez A, Castillo A, Alfaro Y, de la Torre R, Barbanoj MJ. Determination of N,N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of ayahuasca. J Chromatogr B Anal Technol Biomed Life Sci 2002; 779: 271-281
- 60 Silveira GO, Lourenço FR, Bruno V, Yonamine M. Fast hollow fiber liquid-phase microextraction as a greener alternative for the determination of N,N-dimethyltryptamine and harmala alkaloids in human urine. Front Chem 2020; 8: 558501
- 61 Callaway JC, Brito GS, Neves ES. Phytochemical analyses of banisteriopsis caapi and psychotria viridis. J Psychoactive Drugs 2005; 37: 145-150
- 62 Santos BWL, de Oliveira RC, Sonsin-Oliveira J, Fagg CW, Barbosa JBF, Caldas ED. Biodiversity of β-carboline profile of banisteriopsis caapi and ayahuasca, a plant and a brew with neuropharmacological potential. Plants 2020; 9: 870
- 63 Labate BC, Macrae E, Goulart S. eds. Brazilian Ayahuasca Religions in Perspective. In: Ayahuasca, Ritual and Religion in Brazil. London: Taylor and Francis; 2016: 1-20
- 64 Callaway JC. Various alkaloid profiles in decoctions of banisteriopsis caapi. J Psychoactive Drugs 2005; 37: 151-155
- 65 Huhn C, Neusüß C, Pelzing M, Pyell U, Mannhardt J, Pütz M. Capillary electrophoresis-laser induced fluorescence-electrospray ionization-mass spectrometry: A case study. Electrophoresis 2005; 26: 1389-1397
- 66 Pires APS, De Oliveira CDR, Moura S, Dörr FA, Silva WAE, Yonamine M. Gas chromatographic analysis of dimethyltryptamine and β-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage. Phytochem Anal 2009; 20: 149-153
- 67 Gambelunghe C, Aroni K, Rossi R, Moretti L, Bacci M. Identification of N,N-dimethyltryptamine and β-carbolines in psychotropic ayahuasca beverage. Biomed Chromatogr 2008; 22: 1056-1059
- 68 McIlhenny EH, Pipkin KE, Standish LJ, Wechkin HA, Strassman R, Barker SA. Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. J Chromatogr A 2009; 1216: 8960-8968
- 69 Estrella-Parra EA, Almanza-Pérez JC, Alarcón-Aguilar FJ. Ayahuasca: Uses, phytochemical and biological activities. Nat Products Bioprospect 2019; 9: 251-265
- 70 Soares DBS, Duarte LP, Cavalcanti AD, Silva FC, Braga AD, Lopes MTP, Takahashi JA, Vieira-Filho SA. Psychotria viridis: Chemical constituents from leaves and biological properties. An Acad Bras Cienc 2017; 89: 927-938
- 71 Simão AY, Gonçalves J, Gradillas A, García A, Restolho J, Fernández N, Rodilla JM, Barroso M, Duarte AP, Cristóvão AC, Gallardo E. Evaluation of the cytotoxicity of ayahuasca beverages. Molecules 2020; 25: 5594
- 72 Gonçalves J, Luís Â, Gradillas A, García A, Restolho J, Fernández N, Domingues F, Gallardo E, Duarte AP. Ayahuasca beverages: Phytochemical analysis and biological properties. Antibiotics 2020; 9: 731
- 73 Santos MC, Navickiene S, Gaujac A. Determination of tryptamines and β-carbolines in ayahuasca beverage consumed during Brazilian religious ceremonies. J AOAC Int 2017; 100: 820-824
- 74 Luna LE. The healing practices of a Peruvian shaman. J Ethnopharmacol 1984; 11: 123-133
- 75 Jernigan KA. Dietary restrictions in healing among speakers of Iquito, an endangered language of the Peruvian Amazon. J Ethnobiol Ethnomed 2011; 7: 20
- 76 Sanz-Biset J, Cañigueral S. Plant use in the medicinal practices known as “strict diets” in Chazuta valley (Peruvian Amazon). J Ethnopharmacol 2011; 137: 271-288
- 77 OʼShaughnessy DM, Berlowitz I. Amazonian medicine and the psychedelic revival: Considering the “Dieta”. Front Pharmacol 2021; 12: 639124
- 78 Politi M, Rumlerova T, Rojas GS, Rumlerova T, Marcus O, Romero JT, Mabit J. Medicinal plants diet as emerging complementary therapy from the Amazonian tradition. Data from Centro Takiwasi, a Peruvian therapeutic community. J Med Herbs Ethnomedicine 2019; 5: 23-28
- 79 Fotiou E. Technologies of the body in contemporary ayahuasca shamanism in the Peruvian Amazon: Implications for future research. Hum Ecol 2019; 47: 145-151
- 80 Cholewka C, Friso F, Politi M. The use of plants diet in traditional Amazonian medicine: Implications for a new approach in herbal medicine. Phytotherapie 2020; 18: 169-179
- 81 Parise AG, Gagliano M, Souza GM. Extended cognition in plants: Is it possible?. Plant Signal Behav 2020; 15: 1710661
- 82 Calvo P, Gagliano M, Souza G, Trewavas A. Plants are intelligent, hereʼs how. Ann Bot 2020; 125: 11-28
- 83 Baluška F, Mancuso S. Plants, climate and humans: Plant intelligence changes everything. EMBO Rep 2020; 21: e50109
- 84 Attala L. “The Edibility Approach”: Using edibility to explore relationships, plant agency and the porosity of speciesʼ boundaries. Adv Anthropol 2017; 7: 125-145
- 85 Wu X, Wang S, Lu J, Jing Y, Li M, Cao J, Bian B, Hu C. Seeing the unseen of Chinese herbal medicine processing (Paozhi): Advances in new perspectives. Chin Med 2018; 13: 4
- 86 Liu S, Li F, Li Y, Li W, Xu J, Du H. A review of traditional and current methods used to potentially reduce toxicity of Aconitum roots in Traditional Chinese Medicine. J Ethnopharmacol 2017; 207: 237-250
- 87 Politi M, Tresca G, Soffiato M, Garay-Montes R, Mendive F. Phytochemical profiling of Amazonian herbal medicinal products: The role of traditional processing methods. J Med Herbs Ethnomedicine 2019; 5: 1-7
- 88 Tresca G, Marcus O, Politi M. Evaluating herbal medicine preparation from a traditional perspective: Insights from an ethnopharmaceutical survey in the Peruvian Amazon. Anthropol Med 2020; 27: 268-284
- 89 Popa SL, Chiarioni G, David L, Golea GI, Dumitrascu DL. Functional emesis. J Gastrointest Liver Dis 2019; 28: 319-325
- 90 Keel PK. Purging disorder: Recent advances and future challenges. Curr Opin Psychiatry 2019; 32: 518-524
- 91 Chai D, Jiang H, Li Q. Induced vomiting: A therapeutic option. Int J Clin Exp Med 2016; 9: 17098-17105
- 92 Rastogi S. Effectiveness, safety, and standard of service delivery: A patient-based survey at a pancha karma therapy unit in a secondary care Ayurvedic hospital. J Ayurveda Integr Med 2011; 2: 197-204
- 93 Barrett ME. Wat Thamkrabok: A Buddhist drug rehabilitation program in Thailand. Subst Use Misuse 1997; 32: 435-459
- 94 Yuen H, Hong Yang AW, Hung A, Lenon GB. How does traditional knowledge of Cassiae semen shed light on weight management? – A classical and modern literature review. J Ethnopharmacol 2021; 268: 113572
- 95 Numata T, Sato-Numata K, Okada Y. Herbal components of Japanese Kampo medicines exert laxative actions in colonic epithelium cells via activation of BK and CFTR channels. Sci Rep 2019; 9: 15554
- 96 Junior VH, Martins IA. KAMBÔ: an Amazonian enigma. J Venom Res 2020; 10: 13-17
- 97 Berlowitz I, Torres EG, Walt H, Wolf U, Maake C, Martin-Soelch C. “Tobacco is the chief medicinal plant in my work”: Therapeutic uses of tobacco in Peruvian Amazonian medicine exemplified by the work of a maestro tabaquero. Front Pharmacol 2020; 11: 1
- 98 Kravetz RE. Tobacco enema. Am J Gastroenterol 2002; 97: 2453-2453
- 99 Valassi E, Scacchi M, Cavagnini F. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 2008; 18: 158-168
- 100 Strassman RJ. Adverse reactions to psychedelic drugs. A review of the literature. J Nerv Ment Dis 1984; 172: 577-595
- 101 Brito-da-Costa A, Dias-da-Silva D, Gomes N, Dinis-Oliveira R, Madureira-Carvalho A. Toxicokinetics and toxicodynamics of Ayahuasca alkaloids N, N-Dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: clinical and forensic impact. Pharmaceuticals (Basel) 2020; 13: 1-39
- 102 Cameron L, Olson D. Dark classics in chemical neuroscience: N,N-Dimethyltryptamine (DMT). ACS Chem Neurosci 2018; 9: 2344-2357
- 103 Sanches R, de Lima Osório F, Dos Santos R, Macedo L, Maia-de-Oliveira J, Wichert-Ana L, de Araujo D, Riba J, Crippa J, Hallak J. Antidepressant effects of a single dose of Ayahuasca in patients with recurrent depression: A SPECT study. J Clin Psychopharmacol 2016; 36: 77-81
- 104 Brown C, Mehler P. Medical complications of self-induced vomiting. Eat Disord 2013; 21: 287-294
- 105 Phipps SM, Grundmann O. Pharmacology and Structure-Activity Relationship of natural Products with psychoactive Effects from Salvia divinorum, Mitragyna speciosa, and ayahuasca. In: Atta-ur-Rahman. ed. Studies in Natural Products Chemistry. Amsterdam: Elsevier; 2017: 1-44
- 106 Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ. Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther 2003; 306: 73-83
- 107 Moloudizargari M, Mikaili P, Aghajanshakeri S, Asghari M, Shayegh J. Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacogn Rev 2013; 7: 199-212
- 108 Lanaro R, Calemi DB, Togni LR, Costa JL, Yonamine M, Cazenave SOS, Linardi A. Ritualistic use of ayahuasca versus street use of similar substances seized by the police: A key factor involved in the potential for intoxications and overdose?. J Psychoactive Drugs 2015; 47: 132-139
- 109 Frison G, Favretto D, Zancanaro F, Fazzin G, Ferrara SD. A case of β-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Forensic Sci Int 2008; 179: e37-43
- 110 Martin-Gronert MS, Stocker CJ, Wargent ET, Cripps RL, Garfield AS, Jovanovic Z, DʼAgostino G, Yeo GSH, Cawthorne MA, Arch JRS, Heisler LK, Ozanne SE. 5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats. DMM Dis Model Mech 2016; 9: 401-412
- 111 Demirbugen OM, Uckun Z, Yuce-Artun N, Baskak B, Ozdemir H, Kizil Ozel T, Devrimci Ozguven H, Suzen HS. The relationship between the serotonin 2A receptor gene − 1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients. Hum Psychopharmacol 2018; 33: e2673
- 112 Wolff MC, Leander JD. A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon. Behav Pharmacol 2000; 11: 355-364
- 113 Wu Q, Kuca K, Nepovimova E, Wu W. Type a trichothecene diacetoxyscirpenol-induced emesis corresponds to secretion of peptide yy and serotonin in mink. Toxins (Basel) 2020; 12: 419
- 114 Kannen V, Bader M, Sakita JY, Uyemura SA, Squire JA. The dual role of serotonin in colorectal cancer. Trends Endocrinol Metab 2020; 31: 611-625
- 115 Orlando G, Recinella L, Chiavaroli A, Brunetti L, Leone S, Carradori S, Di Simone S, Ciferri MC, Zengin G, Ak G, Abdullah HH, Cordisco E, Sortino M, Svetaz L, Politi M, Angelini P, Covino S, Venanzoni R, Cesa S, Menghini L, Ferrante C. Water extract from inflorescences of industrial hemp futura 75 variety as a source of anti-inflammatory, anti-proliferative and antimycotic agents: Results from in silico, in vitro and ex vivo studies. Antioxidants 2020; 9: 437
- 116 Ferrante C, Recinella L, Ronci M, Orlando G, Di Simone S, Brunetti L, Chiavaroli A, Leone S, Politi M, Tirillini B, Angelini P, Covino S, Venanzoni R, Vladimir-Knežević S, Menghini L. Protective effects induced by alcoholic Phlomis fruticosa and Phlomis herba-venti extracts in isolated rat colon: Focus on antioxidant, anti-inflammatory, and antimicrobial activities in vitro. Phyther Res 2019; 33: 2387-2400
- 117 Bouso JC, González D, Fondevila S, Cutchet M, Fernández X, Ribeiro Barbosa PC, Alcázar-Córcoles MÁ, Araújo WS, Barbanoj MJ, Fábregas JM, Riba J. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: A longitudinal study. PLoS One 2012; 7: e42421
- 118 Sampedro F, Revenga MDLF, Valle M, Roberto N, Domínguez-Clavé E, Elices M, Luna LE, Crippa JAS, Hallak JEC, Araujo DBD, Friedlander P, Barker SA, Álvarez E, Soler J, Pascual JC, Feilding A, Riba J. Assessing the psychedelic “after-glow” in ayahuasca users: Post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. Int J Neuropsychopharmacol 2017; 20: 698-711
- 119 Hery F, Hamon M. Neuroleptics and serotonin. Encephale 1993; 19: 525-532
- 120 Maiuolo J, Gliozzi M, Musolino V, Carresi C, Scarano F, Nucera S, Scicchitano M, Oppedisano F, Bosco F, Ruga S, Zito MC, Macri R, Palma E, Muscoli C, Mollace V. The contribution of gut microbiota–Brain axis in the development of brain disorders. Front Neurosci 2021; 15: 616883
- 121 Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res 2018; 1693: 128-133
- 122 Thompson C, Szabo A. Psychedelics as a novel approach to treating autoimmune conditions. Immunol Lett 2020; 228: 45-54
- 123 Ahmad A, Khan K, Sultana S, Siddiqui B, Begum S, Faizi S, Siddiqui S. Study of the in vitro antimicrobial activity of harmine, harmaline and their derivatives. J Ethnopharmacol 1992; 35: 289-294
- 124 Salman S, Idrees F, Pervaiz S, Shah FH, Badshah S, Usman M, Halimi SA, Idrees J, Wali Khan A. Evaluation of antimicrobial activities of harmine, harmaline, nicotine and their complexes. Pak J Pharm Sci 2016; 29: 1317-1320
- 125 Kuypers KPC. Psychedelic medicine: The biology underlying the persisting psychedelic effects. Med Hypotheses 2019; 125: 21-24
- 126 Dev L. Plant Knowledges: Indigenous Approaches and Interspecies listening toward decolonizing Ayahuasca Research. In: Labate B, Cavnar C. eds. Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives. Cham: Springer; 2018: 185-204
- 127 Reyes-García V. The relevance of traditional knowledge systems for ethnopharmacological research: Theoretical and methodological contributions. J Ethnobiol Ethnomed 2010; 6: 32
- 128 Etkin NL. Cultural Constructions of Efficacy. In: VanDerGeest S, Whyte SR. eds. The Context of Medicines in Developing Countries: Studies in Pharmaceutical Anthropology. Dordrecht: Kluwer Academic Publishers; 1988: 299-327
- 129 Legare C, Souza A. Evaluating ritual efficacy: Evidence from the supernatural. Cognition 2012; 124: 1-15
- 130 Quack J, Sax WS. Introduction: The efficacy of rituals. J Ritual Stud 2010; 24: 5-12
- 131 Požgain I, Požgain Z, Degmečić D. Placebo and nocebo effect: A mini-review. Psychiatr Danub 2014; 26: 100-107
- 132 Perkins D, Schubert V, Simonová H, Tófoli LF, Bouso JC, Horák M, Galvão-Coelho NL, Sarris J. Influence of context and setting on the mental health and wellbeing outcomes of Ayahuasca drinkers: Results of a large international survey. Front Pharmacol 2021; 12: 623979
- 133 Nutt D. Psychedelic drugs–a new era in psychiatry?. Dialogues Clin Neurosci 2019; 21: 139-147
- 134 Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM. Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry 2020; 177: 391-410